Paion AG
PA8
Kedudukan dalam Saham
#35823
Paion AG is a specialized pharmaceutical firm engaged in the global development... Paion AG is a specialized pharmaceutical firm engaged in the global development and commercialization of medicines for hospital settings, specifically addressing needs in sedation, anesthesia, and critical care. Its primary compound, Remimazolam, is an ultra-short-acting intravenous benzodiazepine designed as a sedative/anesthetic, currently progressing through clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline also includes Angiotensin II, a vasoconstrictor for treating severe low blood pressure in adults experiencing septic or other forms of distributive shock, and Eravacycline, a new fluorocycline antibiotic targeting complex intra-abdominal infections in adults. Paion AG collaborates with various partners through licensing and strategic agreements, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Established in 2000, Paion AG operates from Aachen, Germany.
Harga Saham
$0.42701586
Disegerakkan terakhir: 2023-11-01
Modal Pasaran
$3.21M
Perubahan (1 hari)
16.99%
Perubahan (1 tahun)
3,114.29%
Negara
DE
Perdagangan Paion AG (PA8)
Kategori
Healthcare
Sejarah pecahan saham untuk Paion AG (PA8)
Saham Paion AG (simbol: PA8) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham PA8 yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham PA8.
Pecahan saham terkini berlaku pada Oct 20, 2026.
Satu saham PA8 yang dibeli sebelum Oct 20, 2026 kini bersamaan dengan 0 saham PA8.
Senarai pecahan saham
| Tahun | Pecahan | Gandaan | Gandaan Kumulatif |
|---|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | |||
Pecahan saham untuk syarikat pesaing atau serupa
| Syarikat | Bilangan pecahan saham | Gandaan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
